RxTeach
  • Home
  • Clinical Pharmacy
  • Journal Clubs
  • Pharmacy Industry
  • Health & Wellness
  • Students
  • Donations
  • About
  • Day in the Life
  • Science
  • Connect with us!
Sign in Subscribe
Clinical Pharmacy

Let's Talk Vancomycin: Part 2

Today, we’ll continue our deep dive with vanc and learn more about how we might approach dosing and calculations!

  • Justin Shiau, PharmD

Justin Shiau, PharmD

20 Feb 2025 • 16 min read
Let's Talk Vancomycin: Part 2
Photo by insung yoon / Unsplash

This post is for subscribers only

Subscribe now

Already have an account? Sign in

ACLS Pharmacotherapy Review: Part 3
Members only

ACLS Pharmacotherapy Review: Part 3

19 Mar 2026 10 min read
Acute Multiple Sclerosis Exacerbation: A Quick Overview

Acute Multiple Sclerosis Exacerbation: A Quick Overview

Although the precise cause of MS remains unclear, current evidence suggests that the disease develops when genetically susceptible individuals encounter environmental triggers that initiate immune-mediated damage within the central nervous system
18 Mar 2026 5 min read
AHA/ACC 2026 Acute PE Guidelines: What You Need to Know
Members only

AHA/ACC 2026 Acute PE Guidelines: What You Need to Know

11 Mar 2026 5 min read
RxTeach © 2026
Powered by Ghost